Partner With Us
Fostering collaborations to break barriers to innovation
Delivery is the bedrock of gene therapy
Driven by our commitment to transform patient lives, we aim to make gene therapy safer, more effective and more accessible by developing next-generation delivery technologies that are available for out-licensing. We are on a mission to create a suite of effective tools designed to be highly targeted and applicable to neuromuscular and cardiac indications, and that are supported by extensive preclinical data to help you accelerate development.
Together, we can revolutionize gene therapy.
see "attributes' tool for settings for this row
Introducing POLARIS-101™: Our North Star in Muscle-Targeted Gene Therapy
The same AAV-SLB101 capsid. New identity.
Robust transduction, biodistribution and expression achieved in multiple animal models and in initial participants dosed in the Phase 1/2 INSPIRE DUCHENNE clinical trial (NCT06138639)
Reduced liver biodistribution observed in data from the INSPIRE DUCHENNE clinical trial and in nonclinical studies
Comprehensive preclinical data available to support regulatory discussions and de-risk development
Express MTAs and flexible licensing available to accelerate access for academic and corporate partners
Agreements, including licenses, executed with corporations, institutions and academic labs for use of POLARIS-101™ (AAV-SLB101) announced as of January 13, 2026
Learn more about POLARIS-101™:
View corporate presentation:
View select scientific presentations:
ASGCT 2026
ASGCT 2026
ASGCT 2026
Some of our partners:
Solid brings together the best knowledge and expertise to rapidly and responsibly advance innovative science. We value our existing partnerships and are always actively looking to establish new ones, working collectively towards a day when patients can live better lives.
Following is the jquery code that sets the body class to the page without a photo hero
PARTNER WITH US NOTICE
Information submitted through this form will be used by Solid Biosciences Inc. to review and respond to your business development inquiry, evaluate potential research, licensing, collaboration, or other partnering opportunities, conduct appropriate diligence, and maintain records of our communications. Please provide only non-confidential information at this stage and do not submit patient-identifiable, health, genetic, or other sensitive personal information. Submission of information does not create a confidential relationship or other obligation unless Solid has separately agreed in writing. For more information about how Solid processes Personal Information, please review our Privacy Policy.